A promising new study has identified a highly accurate, non-invasive method to diagnose non-small cell lung cancer (NSCLC) ...

Aspyre Lung is a targeted biomarker panel of 114 genomic variants across 11 guideline-recommended genes with simultaneous DNA and RNA for non–small cell lung cancer (NSCLC). In this study, we ...

AstraZeneca has launched a pioneering observational study titled ‘Implementation of a Lung Cancer Screening Program in a Public Service, Using Low-dose Tomography and Metabolomics Evaluation.’ The ...

Comparative analysis of immunotherapy treatments in non-small cell lung cancer (NSCLC) using novel causal machine learning approaches.

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a proposed collaboration with Guardant Health, I ...

“This certainly changes things big time,” Dr. Vivek Yadav said. “Because approximately 50% of lung cancer is diagnosed when it’s already metastasized to different parts of the body and it ...

Building on these insights, the team developed a machine learning tool to predict how patients with advanced lung cancer might respond to immunotherapy.

A groundbreaking medical machine could be the key to early detection for lung cancer. Politician suffers stroke live on air during interview NRL fans react after Allana Ferguson backs Greg Inglis ...

Researchers conducted a prospective, longitudinal cohort study involving individuals with current or former habit, who had low-dose CT screening, in London.